Apitherapy (using bee products) has gained broad recognition in cancer therapeutics
globally. Honeybee venom has a broad range of biological potential, and its utilization is …

The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known
as statins, are administered as first-line therapy for hypercholesterolemia, both as primary …

With rapidly growing knowledge in bioinformatics related to peptides and proteins, amino
acid-based drug-design strategies have recently gained importance in pharmaceutics. In the …

Cancer development is associated with abnormal proliferation, genetic instability, cell death
resistance, metabolic reprogramming, immunity evasion, and metastasis. These alterations …

High glucose levels in diabetic patients are implicated in delay wound healing that could
lead to more serious clinical complications. The aim of the present work was to examine the …

During the past decade,“membrane lipid therapy”, which involves the regulation of the
structure and function of tumor cell plasma membranes, has emerged as a new strategy for …

As a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, Fluvastatin (FLV) is
used for reducing low-density lipoprotein (LDL) cholesterol as well as to prevent …

Piceatannol (PIC) is a naturally occurring polyphenolic stilbene, and it has pleiotropic
pharmacological properties. Moreover, PIC has cytotoxic actions among various cancer …

Certain anticancer agents selectively target the nucleus of cancer cells. One such drug is 2-
methoxyestradiol (2ME), which is used for treating lung cancer. To improve the therapeutic …

Background Ovarian cancer treatment is challenged by resistance and off-target effects.
Melittin shows promise against cancer but is limited by its instability and harmful cellular …